BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 32975865)

  • 1. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases.
    Yao Y; Wang H; Liu Z
    Clin Exp Allergy; 2020 Dec; 50(12):1313-1324. PubMed ID: 32975865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa.
    Takabayashi T; Yoshida K; Imoto Y; Schleimer RP; Fujieda S
    Am J Rhinol Allergy; 2022 Jan; 36(1):115-122. PubMed ID: 34232770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
    Kimura H; Francisco D; Conway M; Martinez FD; Vercelli D; Polverino F; Billheimer D; Kraft M
    J Allergy Clin Immunol; 2020 Jul; 146(1):80-88.e8. PubMed ID: 32422146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
    Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
    Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis.
    Soni S; Jiang Y; Tesfaigzi Y; Hornick JL; Çataltepe S
    PLoS One; 2021; 16(2):e0247510. PubMed ID: 33626084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2 expression in allergic airway disease may decrease the risk and severity of COVID-19.
    Chhapola Shukla S
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2637-2640. PubMed ID: 33025046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Disease 2019 and Nasal Conditions: A Review of Current Evidence.
    Suzaki I; Kobayashi H
    In Vivo; 2021; 35(3):1409-1417. PubMed ID: 33910818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.
    Song J; Zeng M; Wang H; Qin C; Hou HY; Sun ZY; Xu SP; Wang GP; Guo CL; Deng YK; Wang ZC; Ma J; Pan L; Liao B; Du ZH; Feng QM; Liu Y; Xie JG; Liu Z
    Allergy; 2021 Feb; 76(2):483-496. PubMed ID: 32716553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease.
    Tomchaney M; Contoli M; Mayo J; Baraldo S; Li S; Cabel CR; Bull DA; Lick S; Malo J; Knoper S; Kim SS; Tram J; Rojas-Quintero J; Kraft M; Ledford JG; Tesfaigzi Y; Martinez FD; Thorne CA; Kheradmand F; Campos SK; Papi A; Polverino F
    BMC Pulm Med; 2021 Aug; 21(1):275. PubMed ID: 34425811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
    Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated FiO
    Myti D; Gunjak M; Casado F; Khaghani Raziabad S; Nardiello C; Vadász I; Herold S; Pryhuber G; Seeger W; Morty RE
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L670-L674. PubMed ID: 32878480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
    Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
    Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps.
    Wang M; Bu X; Fang G; Luan G; Huang Y; Akdis CA; Wang C; Zhang L
    Allergy; 2021 Mar; 76(3):789-803. PubMed ID: 33210729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intersubject Variation in ACE2 Protein Expression in Human Airway Epithelia and Its Relationship to Severe Acute Respiratory Syndrome Coronavirus 2.
    Li K; Wohlford-Lenane C; Bartlett JA; McCray PB
    J Infect Dis; 2021 Oct; 224(8):1357-1361. PubMed ID: 34289058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?
    Nawijn MC; Timens W
    Mol Syst Biol; 2020 Jul; 16(7):e9841. PubMed ID: 32715628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers.
    Nakayama T; Lee IT; Jiang S; Matter MS; Yan CH; Overdevest JB; Wu CT; Goltsev Y; Shih LC; Liao CK; Zhu B; Bai Y; Lidsky P; Xiao Y; Zarabanda D; Yang A; Easwaran M; Schürch CM; Chu P; Chen H; Stalder AK; McIlwain DR; Borchard NA; Gall PA; Dholakia SS; Le W; Xu L; Tai CJ; Yeh TH; Erickson-Direnzo E; Duran JM; Mertz KD; Hwang PH; Haslbauer JD; Jackson PK; Menter T; Andino R; Canoll PD; DeConde AS; Patel ZM; Tzankov A; Nolan GP; Nayak JV
    Cell Rep Med; 2021 Oct; 2(10):100421. PubMed ID: 34604819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.